651 filings
Page 15 of 33
8-K
z43yygd11ps4b 6x
4 May 17
Aviragen Therapeutics Reports Third Quarter Fiscal Year 2017 Financial Results
12:00am
8-K
vapxw3rck9o
4 Apr 17
Aviragen Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update
12:00am
8-K
ewjy1dyfkv embr12
3 Apr 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
x30rdf7tbc790i5yp0e8
13 Feb 17
Aviragen Therapeutics Announces Top-Line Results from Phase 2b SPIRITUS Trial of Vapendavir
12:00am
8-K
pjhxrommquc qqv
3 Feb 17
Aviragen Therapeutics Reports Second Quarter Fiscal Year 2017 Financial Results
12:00am
8-K
hfg9606glhlj
2 Feb 17
Aviragen Therapeutics Announces Top-Line Results from Phase 2a RSV Challenge Study of BTA585
12:00am
8-K
pqxq7i2opz5zpj
9 Jan 17
Regulation FD Disclosure
12:00am
S-8
fxj fdzybyttdi
16 Dec 16
Registration of securities for employees
12:00am
8-K
k99fu gpbx1yor68999s
10 Nov 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
r83cxv
3 Nov 16
Aviragen Therapeutics Reportsfirst Quarter Fiscal Year 2017FINANCIAL Results
12:00am
8-K
qljnh
11 Oct 16
Other Events
12:00am
8-K
vx7wfi6m
15 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
qqt7txdrzlyzo
13 Jul 16
Other Events
12:00am
CT ORDER
gnfq12ai6
11 Jul 16
Confidential treatment order
12:00am
8-K
2p37gna
26 May 16
Aviragen Therapeutics Provides Update on Phase 2a Trial ofBTA585 for the Treatment of RSV Infections
12:00am